Diakonos Oncology will present clinical data on DOC1021 (dubodencel) for pancreatic cancer and glioblastoma at AACR and AAN 2026. The news was shared on 18-Mar-2026 through a release from Diakonos Oncology on PR Newswire. The headline should reflect "AAN 2026" as updated by the company.